CELIAC DISEASE

Clinical trials for CELIAC DISEASE explained in plain language.

Never miss a new study

Get alerted when new CELIAC DISEASE trials appear

Sign up with your email to follow new studies for CELIAC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 22 Not yet recruiting 2 Not yet finished but already full! 6 Completed 13 Terminated 1

New drug aims to tame gluten reaction in celiac disease

Disease control Terminated

This study tested an experimental drug called KAN-101 in people with celiac disease. The goal was to see if it could safely reduce the immune response to gluten. The trial included 128 participants and was split into phases to check safety and how the body processes the drug. How…

Matched conditions: CELIAC DISEASE

Phase: PHASE1, PHASE2 • Sponsor: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC

CELIAC DISEASE

Get alerted when new CELIAC DISEASE trials appear

New drug aims to tame gluten reaction in celiac disease